Description |
Skullcapflavone II, a flavonoid derived from Scutellaria baicalensis, has anti-inflammatory, anti-microbial activities. Skullcapflavone II regulates osteoclast differentiation, survival, and function. Skullcapflavone II exerts potent antimicrobial activity against M. aurum and M. bovis BCG[1][2].
|
In Vitro |
Skullcapflavone II inhibits osteoclastogenesis with decreased activation of MAPKs, Src, and cAMP response element-binding protein (CREB), which have been known to be redox sensitive. Skullcapflavone II decreases reactive oxygen species by scavenging them or activating nuclear factor-erythroid 2-related factor 2 (Nrf2), and its effects were partially reversed by hydrogen peroxide cotreatment or Nrf2 deficiency[2].
|
In Vivo |
Skullcapflavone II, a potential bradykinin antagonist, reduces the major pathophysiological features of allergic asthma, at least in part by acting on TGF-β1/Smad signaling pathways[3].
|
Density | 1.4±0.1 g/cm3 |
Boiling Point | 636.9±55.0 °C at 760 mmHg |
Flash Point | 230.9±25.0 °C |
Exact Mass | 374.100159 |
PSA | 107.59000 |
LogP | 1.58 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |